Check the full bill

Ask for the whole bill.

A headline price leaves room for unanswered costs. Ask for the visit, the medicine and the later care to be listed apart.

There is no official drug price to quote

With no approved BPC-157 medicine in September 2026, neither a medicine maker nor a government source has an official price for it.

This guide cannot give you a usual treatment price. Ask the service for a written total for the care it is offering. You still need answers about whether the treatment works and whether the pharmacy may make it.

Separate amber paper pieces fit together beside an open cream envelope. — Put the separate charges into the same picture.

Ask what each part pays for

Visit: What pays for the assessment, even if no treatment follows?
Medicine: Is it included, or is that a separate charge?
Tests: Who orders them, and who sends the bill?
Follow-up: Are later questions and visits covered by this fee?
Delivery: Is there any separate delivery or handling charge?
Renewal: What repeats, at what rate, and how does cancellation work?

Make the comparison like for like

Pick a span to compare, such as the first month or the whole proposed treatment. Ask every service to quote that same span, including all visits, medicine, tests and charges that repeat. If a charge is unknown, mark it as an open question rather than filling in a guess.

Separate a promotion from the continuing fee

Ask whether the displayed price is introductory, requires paying ahead, or changes when the plan renews. Ask what is charged if the doctor declines the treatment and whether any payment can be refunded. Keep the written terms with the quote.

A clear cost does not settle approval

FDA record · approval

Keep the status question beside the bill

BPC-157 still has no FDA-approved use in the September 2026 record.

Reviewing medicines in the US is FDA’s job. An itemised bill can answer a cost question; it cannot supply a medicine approval.

Read the FDA’s review